Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
暂无分享，去创建一个
N. Ibrahim | M. Fakih | S. Piha-Paul | M. Shah | N. Mizuno | M. Lolkema | J. Strosberg | E. Grande | R. Shapira-Frommer | B. O'Neil | J. Delord | T. Doi | E. Bergsland | Sajev Thomas | J. Hadoux | K. Norwood | S. Takahashi | Menghui Chen | M. Shah